Valuation: VISD GP

Market Cap 4.84Cr 5.58Cr 4.52Cr 4.15Cr 7.85Cr 530.69Cr 7.93Cr 53Cr 21Cr 265.28Cr 21Cr 20Cr 879Cr P/E 2024
44.3x
P/E 2025 31.3x
Enterprise Value 4.86Cr 5.59Cr 4.53Cr 4.16Cr 7.87Cr 532.06Cr 7.95Cr 53Cr 21Cr 265.97Cr 21Cr 21Cr 881.27Cr EV / Sales 2024
3.3x
EV / Sales 2025 3.04x
Free-Float
99.83%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 36 22/01/2024
Investor Relations Contact - -
Chief Executive Officer - 01/04/2022
Director TitleAgeSince
Chairman - -
Director/Board Member - 01/04/2022
Director/Board Member 51 14/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
-0.68%-4.46%+69.99%+43.31% 13TCr
-2.09%-4.99%+9.39%+47.87% 8.8TCr
-0.92%+0.14%+6.92%+58.15% 2.9TCr
+0.60%-0.95%+35.53%+72.28% 2.56TCr
+0.38%+3.15%-8.12%-16.06% 2.22TCr
-0.08%-5.14%+54.67%+234.49% 2.01TCr
-2.62%-3.60%+65.45%+112.15% 1.5TCr
+0.47%-0.32%+3.04%-1.95% 1.47TCr
-7.58%-4.18%-4.27%-11.86% 1.37TCr
Average -1.37%+1.33%+25.84%+59.82% 4.03TCr
Weighted average by Cap. -1.14%+0.98%+36.48%+53.55%

Financials

2024 2025
Net sales 1.73Cr 1.99Cr 1.61Cr 1.48Cr 2.8Cr 189.08Cr 2.83Cr 19Cr 7.42Cr 95Cr 7.46Cr 7.3Cr 313.19Cr 2.22Cr 2.55Cr 2.07Cr 1.9Cr 3.59Cr 242.83Cr 3.63Cr 24Cr 9.53Cr 121.39Cr 9.59Cr 9.38Cr 402.21Cr
Net income 14.05L 16.18L 13.1L 12.03L 22.76L 15Cr 23.01L 1.54Cr 60.37L 7.69Cr 60.76L 59.43L 25Cr 22.81L 26.27L 21.27L 19.54L 36.95L 25Cr 37.36L 2.51Cr 98.02L 12Cr 98.65L 96.49L 41Cr
Net Debt 25.75L 29.66L 24.01L 22.06L 41.71L 28Cr 42.17L 2.83Cr 1.11Cr 14Cr 1.11Cr 1.09Cr 47Cr 1L 1L 1L 1L 2L 1.37Cr 2L 13.74L 5L 68.45L 5L 5L 2.27Cr
Logo VISD GP
Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.
Employees
-